Still, the enhanced disease progression observed in APRIL overexpressing TCL1 mice occurs at APRIL concentrations comparable to our human in vitro system, and clearly suggests that in the in vivo context APRIL contributes to CLL progression. The gene discussed is TNFSF13; the disease is B-cell chronic lymphocytic leukemia.